1983
DOI: 10.1002/mus.880060903
|View full text |Cite
|
Sign up to set email alerts
|

The neurotoxins 2,5‐hexanedione and acrylamide promote aggregation of intermediate filaments in cultured fibroblasts

Abstract: Axonal swellings associated with large aggregates of neurofilaments are characteristic of neuropathies caused by chemical neurotoxins (n-hexane, methyl n-butyl ketone, and acrylamide) or giant axonal neuropathy (GAN--an autosomal recessive genetic disease). In GAN, filamentous aggregates have been shown also to occur in other cell types including cultured skin fibroblasts. Therefore, we studied the effects of 2,5-hexanedione (the neurotoxic metabolite of n-hexane and methyl n-butyl ketone) and acrylamide on no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
31
2

Year Published

1985
1985
2009
2009

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 76 publications
(36 citation statements)
references
References 20 publications
3
31
2
Order By: Relevance
“…3F). Consistent with literature reports (20,47), actin stress fiber disassembly but no microtubule depolymerization was detected in ACR-treated cells (data not shown). As the emergence of nuclear folds has been described to occur in some vimentin null cells, in cells expressing vimentin mutants or containing thick IF bundles, and in ACRtreated neurons (33,43,76,78), we used the percentage of cells with nuclear invaginations as an estimate of the extent of IF disruption.…”
Section: Viral Entry Does Not Alter Vimentin If Structuresupporting
confidence: 93%
See 2 more Smart Citations
“…3F). Consistent with literature reports (20,47), actin stress fiber disassembly but no microtubule depolymerization was detected in ACR-treated cells (data not shown). As the emergence of nuclear folds has been described to occur in some vimentin null cells, in cells expressing vimentin mutants or containing thick IF bundles, and in ACRtreated neurons (33,43,76,78), we used the percentage of cells with nuclear invaginations as an estimate of the extent of IF disruption.…”
Section: Viral Entry Does Not Alter Vimentin If Structuresupporting
confidence: 93%
“…ACR treatment of HF induced cell rounding and contraction, accompanied by the aggregation of vimentin IF in elongated bundles extending into the cells' retraction fibers (Fig. 3A to E) (2,20) and by the appearance of invaginations or folds in the nuclear envelope (Fig. 3F).…”
Section: Viral Entry Does Not Alter Vimentin If Structurementioning
confidence: 99%
See 1 more Smart Citation
“…The presence of a similar longitudinal redistribution of NF strongly suggests that NF transport is accelerated also in the inherited giant axonal neuropathy. Moreover, disorganization of fibroblast IF has been observed in 2,5-HxD intoxication, suggesting that the effect of this compound involves other types of IF also (50). The elucidation of the precise effect of 2,5-HxD on IF may therefore provide important insight in the genetic defect responsible for the inherited forms of giant axonal neuropathy.…”
Section: A3mentioning
confidence: 99%
“…A number of other small-molecular-weight compounds have also been found to affect cIF organization. These include triethyl lead chloride [Zimmerman et al, 19861, the hexacarbon solvent 2,5-hexanedione [Durham et al, 1983;Durham, 19881, carbon disulfide [Pappolla et al, 19871, acrylamide [Durham et al, 1983;Eckert, 1985;Sager and Matheson, 1988;Klymkowsky, 19881, inhibitors of energy metabolism [Maro and Bornens, 1982;Klymkowsky, 19881, inhibitors of protein synthesis [Sharpe et al, 1980;Klymkowsky, 19881, the amino acid analogue L-azetindine-2-carboxylic acid [Thomas et al, 1982;Klymkowsky, 19881, p,p'-iminodipropionitrile [Clark et al, 1980;Papasozomenos et al, 1981;Griffin et al, 19831, nickel [Katsuma et al, 19871, and the nucleoside analogue cordycepin [Zeive and Roemer, 19881. All cause the collapse of cIFs organization without obvious effects on microtubule organization.…”
Section: New Drugsmentioning
confidence: 99%